These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25609247)

  • 1. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
    van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
    Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
    Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
    J Clin Oncol; 2011 Aug; 29(23):3163-72. PubMed ID: 21747092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients.
    Shen L; van Soest J; Wang J; Yu J; Hu W; Gong YU; Valentini V; Xiao Y; Dekker A; Zhang Z
    Oncotarget; 2015 Nov; 6(35):38327-35. PubMed ID: 26413811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.
    Wang L; Gu GL; Li ZW; Peng YF; Gu J
    World J Gastroenterol; 2014 Jul; 20(27):9138-45. PubMed ID: 25083087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers.
    Peng J; Ding Y; Tu S; Shi D; Sun L; Li X; Wu H; Cai S
    PLoS One; 2014; 9(8):e106344. PubMed ID: 25171093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
    Tsujinaka S; Kawamura YJ; Konishi F; Aihara H; Maeda T; Mizokami K
    Int J Colorectal Dis; 2008 Jan; 23(1):67-76. PubMed ID: 17704925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
    van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
    Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
    J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
    Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
    Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
    van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
    Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
    Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
    J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
    Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
    BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity.
    Kube R; Ptok H; Jacob D; Fahlke J; Mroczkowski P; Lippert H; Ziegenhardt G; Schmidt U; Gastinger I
    Int J Colorectal Dis; 2010 Jan; 25(1):109-17. PubMed ID: 19876634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
    Pach R; Kulig J; Richter P; Gach T; Szura M; Kowalska T
    Langenbecks Arch Surg; 2012 Jun; 397(5):801-7. PubMed ID: 22170083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.